000623.SZ
Jilin Aodong Pharmaceutical Group Co., Ltd.
ShenzhenCNYEQUITY
Healthcare
DELAYED
Last price
17.97
▼ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
17.98
Prev close
17.97
Day high
18.09
Day low
17.82
Volume
9.86M
Market cap
$21.50B
P/E (TTM)
7.68
52W range
16.36 – 22.08
Day trading desk
Gap from prior close
+0.06%
Prior close 17.97
VWAP
17.92
+0.29% from price
Relative volume
1.12×
Normal
Session range
1.52%
17.82 – 18.09
Position in range
56%
Mid range
ATR (14D)
0.34
1.86% of price
Prior day high
18.14
PDH
Prior day low
17.83
PDL
Bid / ask spread
—
Quote not published
Session volume
15.93M
Avg 14.21M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.99%
+0.3%
1M
+1.75%
-1.5%
3M
+2.28%
-0.0%
6M
-4.41%
-16.2%
YTD
-7.94%
-19.8%
1Y
-6.11%
-26.2%
3Y
+14.60%
-60.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 000623.SZ open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
380.00M
Total on file
Fundamentals
Market cap$21.50B
Enterprise value$20.64B
Revenue (TTM)$2.23B
Gross profit$1.02B
EBITDA$38.93M
Net income$2.74B
EPS (TTM)$2.34
Free cash flow$76.48M
Total cash$2.90B
Total debt$2.25B
Book value / share$26.86
Shares outstanding1.20B
Float807.22M
Short % of float—
Dividend yield2.78%
Beta (5Y)0.50
Valuation & profitability ratios
Trailing P/E7.68
Forward P/E8.25
PEG ratio1.33
Price / sales—
Price / book0.67
EV / revenue9.27
EV / EBITDA530.18
Gross margin45.81%
Operating margin4.46%
Profit margin123.25%
Return on equity8.83%
Return on assets-0.27%
Debt / equity7.09
Current ratio2.38
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.34B | $2.61B | $3.45B | $2.87B | -10.5% |
| Operating revenue | $2.34B | $2.61B | $3.45B | $2.87B | -10.5% |
| Cost of revenue | $1.21B | $1.56B | $1.75B | $1.40B | -22.4% |
| Gross profit | $1.13B | $1.05B | $1.70B | $1.47B | +7.1% |
| Research & development | $101.91M | $82.20M | $124.98M | $85.68M | +24.0% |
| Selling, general & admin | $781.83M | $757.36M | $1.08B | $920.33M | +3.2% |
| Total operating expense | $1.19B | $1.12B | $1.43B | $1.23B | +6.1% |
| Operating income | -$62.86M | -$69.22M | $267.04M | $240.37M | +9.2% |
| Net interest income | -$45.04M | -$72.35M | -$113.30M | -$88.25M | +37.7% |
| Pre-tax income | $2.42B | $1.52B | $1.50B | $1.72B | +59.1% |
| Tax provision | $59.32M | $2.23M | $55.83M | -$80.16M | +2,560.4% |
| Net income | $2.40B | $1.55B | $1.46B | $1.78B | +54.4% |
| Net income to common | $2.40B | $1.55B | $1.46B | $1.78B | +54.4% |
| Basic EPS | 2.04 | 1.32 | 1.30 | 1.57 | +54.9% |
| Diluted EPS | 2.04 | 1.32 | 1.23 | 1.47 | +54.9% |
| EBIT | $2.47B | $1.61B | $1.64B | $1.86B | +53.3% |
| EBITDA | $2.69B | $1.85B | $1.88B | $2.09B | +45.4% |
| Basic shares | 1.17B | 1.18B | 1.13B | 1.13B | -0.3% |
| Diluted shares | 1.17B | 1.18B | 1.19B | 1.21B | -0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.16B | $1.11B | $1.72B | $1.44B | — | +5.0% |
| Cash & short-term investments | $2.96B | $2.68B | $3.38B | $3.08B | — | +10.8% |
| Accounts receivable | $666.79M | $787.41M | $1.01B | $688.51M | — | -15.3% |
| Inventory | $802.10M | $936.90M | $872.35M | $874.57M | — | -14.4% |
| Total current assets | $4.82B | $4.83B | $5.75B | $5.98B | — | -0.2% |
| Property, plant & equipment | $2.35B | $2.55B | $2.53B | $2.33B | — | -8.0% |
| Goodwill & intangibles | $439.37M | $542.94M | $591.06M | $561.22M | — | -19.1% |
| Total assets | $34.42B | $33.00B | $32.27B | $31.18B | — | +4.3% |
| Total current liabilities | $2.01B | $2.46B | $4.47B | $2.22B | — | -18.3% |
| Current debt | $903.02M | $1.25B | $678.31M | $651.27M | — | -28.0% |
| Long-term debt | $1.30B | $995.22M | — | $2.30B | $2.21B | +30.6% |
| Total debt | $2.24B | $2.29B | $3.03B | $2.99B | — | -2.2% |
| Total liabilities | $3.53B | $3.72B | $4.77B | $4.84B | — | -5.1% |
| Retained earnings | $21.34B | $19.78B | $19.38B | $18.39B | — | +7.9% |
| Shareholder equity | $30.67B | $29.03B | $27.21B | $26.03B | — | +5.6% |
| Working capital | $2.81B | $2.37B | $1.28B | $3.77B | — | +18.6% |
| Net tangible assets | $30.23B | $28.48B | $26.62B | $25.47B | — | +6.1% |
| Shares issued | 1.20B | 1.20B | 1.17B | 1.16B | — | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $2.36B | $1.52B | $1.44B | $1.80B | +55.4% |
| Depreciation & amortisation | $214.73M | $234.51M | $233.87M | $225.63M | -8.4% |
| Change in working capital | $158.13M | -$126.09M | -$422.39M | -$170.12M | +225.4% |
| Operating cash flow | $272.26M | $59.48M | $68.06M | $423.86M | +357.7% |
| Capital expenditure | -$128.45M | -$273.98M | -$419.52M | -$270.97M | +53.1% |
| Investing cash flow | $610.41M | $436.44M | $763.62M | -$553.21M | +39.9% |
| Dividends paid | -$649.03M | -$1.06B | -$400.57M | -$377.76M | +38.8% |
| Financing cash flow | -$835.35M | -$1.11B | -$549.21M | -$171.07M | +24.7% |
| Free cash flow | $143.81M | -$214.50M | -$351.46M | $152.89M | +167.0% |
| End cash position | $1.15B | $1.11B | $1.72B | $1.44B | +4.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $514.09M | $694.88M | $503.75M | $622.62M | $701.07M | -26.0% |
| Operating revenue | $514.09M | $694.88M | $503.75M | $622.62M | $701.07M | -26.0% |
| Cost of revenue | $265.19M | $340.84M | $251.67M | $329.28M | $397.05M | -22.2% |
| Gross profit | $248.91M | $354.03M | $252.08M | $293.35M | $304.02M | -29.7% |
| Research & development | $14.36M | $50.31M | $18.17M | $13.12M | $26.39M | -71.4% |
| Selling, general & admin | $194.13M | $71.51M | $144.36M | $266.07M | $53.37M | +171.5% |
| Total operating expense | $209.25M | $422.83M | $247.85M | $279.19M | $378.23M | -50.5% |
| Operating income | $39.66M | -$68.79M | $4.23M | $14.16M | -$74.21M | +157.6% |
| Net interest income | -$13.79M | -$15.41M | -$12.77M | -$2.67M | -$12.06M | +10.5% |
| Pre-tax income | $865.54M | $76.89M | $790.82M | $529.16M | $267.83M | +1,025.6% |
| Tax provision | $446.06K | -$29.05M | $28.83M | $12.65M | -$32.81M | +101.5% |
| Net income | $866.00M | $134.74M | $764.70M | $516.84M | $307.28M | +542.7% |
| Net income to common | $866.00M | $134.74M | $764.70M | $516.84M | $307.28M | +542.7% |
| Basic EPS | 0.74 | — | — | 0.44 | — | — |
| Diluted EPS | 0.74 | — | — | 0.44 | — | — |
| EBIT | $880.80M | $92.61M | $805.02M | $535.30M | $282.83M | +851.1% |
| EBITDA | $880.80M | $92.61M | $805.02M | $535.30M | $282.83M | +851.1% |
| Basic shares | 1.17B | — | — | 1.18B | — | — |
| Diluted shares | 1.17B | — | — | 1.18B | — | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.14B | $1.16B | $1.52B | $1.07B | $1.11B | -1.6% |
| Cash & short-term investments | $2.90B | $2.96B | $3.20B | $2.65B | $2.68B | -2.2% |
| Accounts receivable | $701.11M | $666.79M | $788.44M | $933.36M | $787.41M | +5.1% |
| Inventory | $823.10M | $802.10M | $891.04M | $892.79M | $936.90M | +2.6% |
| Total current assets | $4.86B | $4.82B | $5.27B | $4.83B | $4.83B | +0.7% |
| Property, plant & equipment | $2.32B | $2.35B | $2.49B | $2.53B | $2.55B | -1.0% |
| Goodwill & intangibles | $434.30M | $439.37M | $541.21M | $550.57M | $542.94M | -1.2% |
| Total assets | $35.27B | $34.42B | $34.15B | $33.51B | $33.00B | +2.5% |
| Total current liabilities | $2.04B | $2.01B | $2.61B | $2.58B | $2.46B | +1.4% |
| Current debt | $905.62M | $903.02M | $1.15B | $1.35B | $1.25B | +0.3% |
| Long-term debt | $1.30B | $1.30B | $1.09B | $995.71M | $995.22M | +0.0% |
| Total debt | $2.25B | $2.24B | $2.26B | $2.38B | $2.29B | +0.5% |
| Total liabilities | $3.55B | $3.53B | $3.94B | $3.83B | $3.72B | +0.6% |
| Retained earnings | $22.21B | $21.34B | $20.71B | $20.30B | $19.78B | +4.1% |
| Shareholder equity | $31.49B | $30.67B | $29.96B | $29.43B | $29.03B | +2.7% |
| Working capital | $2.81B | $2.81B | $2.66B | $2.25B | $2.37B | +0.2% |
| Net tangible assets | $31.06B | $30.23B | $29.42B | $28.88B | $28.48B | +2.8% |
| Shares issued | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Capital expenditure | -$26.36M | -$37.40M | -$22.99M | -$42.26M | -$47.59M | +29.5% |
| Investing cash flow | -$26.19M | $100.07M | $505.70M | -$57.84M | $169.65M | -126.2% |
| Dividends paid | -$6.16M | -$240.94M | -$42.56M | -$7.04M | -$246.40M | +97.4% |
| Financing cash flow | -$4.61M | -$272.08M | -$151.54M | -$39.77M | -$437.60M | +98.3% |
| Free cash flow | -$15.66M | $73.81M | $74.05M | $13.69M | $58.76M | -121.2% |
| End cash position | $1.13B | $1.15B | $1.52B | $1.06B | $1.11B | -1.8% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders32.41%
Held by institutions8.48%
Institutions holding117
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
18.04
-0.38% from price
SMA 20
18.12
-0.80% from price
SMA 50
18.10
-0.67% from price
SMA 100
17.97
+0.01% from price
SMA 200
18.74
-4.04% from price
EMA 12
18.05
-0.46% from price
EMA 26
18.08
-0.62% from price
EMA 50
18.06
-0.51% from price
RSI (14)
48.0
Neutral
MACD (12,26,9)
-0.03
Hist -0.03
ATR (14)
0.34
1.86% of price
Realised vol 30D
25.8%
Annualised
Bollinger upper
18.46
20, 2σ
Bollinger lower
17.79
20, 2σ
50 / 200 cross
Death
18.10 vs 18.74
Trend bias
Below 200
-4.04%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.22
Less volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
25.8%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-24.3%
Peak to trough
Max drawdown 5Y
-31.8%
Peak to trough
ATR 14
0.34
1.86% of price
Beta (reported)
0.50
5Y monthly, from filing
Dividends & splits
Forward rate$0.50 / yr
Forward yield2.78%
5-year avg yield2.50%
Payout ratio21.36%
Ex-dividend dateJul 8, 2026
Next pay date—
Last split13:10
Split dateJun 19, 2017
Headlines
Kenyan farmers turn to bugs as organic demand grows
AFP · 3m ago
FRN Variable Rate Fix
Business Wire · 4m ago
IHCL to merge Oriental Hotels under proposed share-swap deal
Hotel Management Network · 5m ago
Houlihan Lokey (HLI): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 7m ago
Hohhot, Inner Mongolia: Converting Prairie Winds into Computing Power
ACCESS Newswire · 7m ago
LIVE: US unveils new sanctions on Iran
Yahoo Finance Video · 8m ago
CPK chooses T-ROC Global to deploy automated food kiosks
Verdict Food Service · 9m ago
New IFT White Paper Provides Blueprint for Building a Future-Ready Food Science Workforce
Business Wire · 9m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.